Merck, Seagen and Astellas Get Late-Stage Win in Bladder Cancer with Combo

cafead

Administrator
Staff member
  • cafead   Sep 22, 2023 at 12:12: PM
via A collaborative Phase III study by Merck, Seagen and Astellas to treat locally advanced and metastatic urothelial cancer hit its dual primary endpoints, the companies announced Friday.

article source